USANA Health Sciences, Inc.

USANA Health Sciences, Inc.

USNA
USANA Health Sciences, Inc.US flagNew York Stock Exchange
14.43
USD
-0.13
- -
266.42MMarket Cap
USANA Health Sciences, Inc.
USNA
(New York Stock Exchange)

Recent

price

14.43

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
16.91
19.48
23.47
25.86
31.29
36.78
41.09
43.59
50.46
48.99
53.93
61.18
51.99
48.14
44.82
50.61
37.58
Revenue per Share
1.49
1.7
2.4
2.85
3.03
3.79
4.09
2.6
5.36
4.64
5.93
6.01
3.61
3.33
2.2
0.59
-0.07
Basic EPS, GAAP
2.02
1.99
3.05
3.27
3.35
3.51
4.26
4.6
5.97
5.09
6.91
5.59
4.87
2.94
2.67
0.47
-0.23
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
4.74
5.82
6.71
9.38
9.11
11.24
13.29
15.12
16.6
16.24
20.99
20.37
22.62
25.99
27.91
29.16
- -
Book Value per Share
2.86
3.8
4.54
7.2
6.78
9.01
11.2
12.93
14.53
14.1
18.7
17.89
20.03
23.53
12.39
14.33
- -
Tangible Book Value per Share
31
30
28
28
25
25
24
24
24
22
21
19
19
19
19
18
18
Basic Weighted Avg Shares
518
582
649
718
790
918
1,006
1,047
1,189
1,061
1,135
1,186
999
921
855
925
690
Sales/Revenue/Turnover
13.18
13.28
15.13
16.25
14.69
15.42
13.78
12.65
15.84
13.78
15.55
14.34
10.78
10.11
7.76
5.5
4.69
Operating Margin (%)
8
8
9
9
9
10
13
16
17
23
23
22
21
20
22
40
30
Depreciation Expense
46
51
66
79
77
95
100
63
126
101
125
117
69
64
42
11
-1
Net Income, GAAP
33.71
34.49
32.5
32.22
33.74
33.6
27.8
53.55
34.09
33.2
29.94
31.73
36.15
37.74
44.91
72.36
106.06
Effective Tax Rate (%)
8.82
8.72
10.24
11
9.69
10.31
9.94
5.97
10.61
9.48
10.99
9.82
6.94
6.93
4.92
1.16
-0.19
Profit Margin (%)
23
46
62
133
82
113
139
199
244
193
257
204
241
299
140
160
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
145
174
186
261
230
281
325
363
391
352
442
395
434
497
586
586
- -
Total Equity
38.2
30.24
35.23
33.67
29.24
34.19
31.1
16.87
31.08
24.77
29.19
26.13
15.68
11.88
6.38
2.26
-0.67
Return on Invested Capital (%)
40.36
31.82
36.97
35.43
31.27
37.06
33.12
18.17
33.47
26.78
30.86
27.34
16.47
13.51
7.52
1.68
-0.48
Return on Capital (%)
41.59
31.81
36.96
35.43
31.24
37.05
33.01
18.17
33.47
27.06
31.43
27.85
16.72
13.69
8.17
2.02
-0.5
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
20
14
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
18
18
18
Market Capitalization
359
322
394

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
288
294
- -
Cash, Cash Equivalents & STI
158
163
- -
Accounts Receivable, Net
- -
10
- -
Inventories
103
96
- -
Total Current Liabilities
129
117
- -
Payables & Accruals
38
16
- -
ST Debt
20
14
- -
Deferred Revenue
11
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.25%
6.36%
-0.01%
Free Cash Flow
-10.93%
-34.33%
-83.26%
Net Income, GAAP
-8.99%
-32.71%
-74.4%
Sales/Revenue/Turnover
0.54%
-3.59%
8.28%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
228
213
200
214
855
2025
250
236
214
226
925
2026
250
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.86
0.55
0.56
0.24
2.2
2025
0.49
0.52
-0.36
-0.1
0.59
2026
0.38
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
USANA Health Sciences, Inc. (NYSE: USNA) develops, manufactures, and markets science-based nutritional supplements, healthy foods, and personal care products sold primarily through a direct-selling network of independent Associates and Preferred Customers worldwide. The company offers core vitamin and mineral supplements under its Essentials and CellSentials lines providing advanced total body nutrition for all age groups from children 13 months onward; targeted Optimizers for cardiovascular, skeletal, digestive, and other specific health needs; low-glycemic USANA Foods including Nutrimeal meal replacement shakes, snack bars, and energy products for macro-nutrition and sustained energy; Celavive skincare systems featuring InCelligence Technology for anti-aging and skin renewal; and active nutrition products for performance and recovery. USANA operates in over 20 markets across Asia Pacific including Greater China, Southeast Asia, North Asia, and India; the Americas; and Europe, with in-house research, development, and manufacturing based in Salt Lake City, Utah, where it was founded in 1992 by Dr. Myron Wentz. In recent developments, USANA completed the acquisition of a 78.8% controlling stake in Hiya Health Products for $205 million in December 2024, adding a direct-to-consumer children's wellness brand with clean-label supplements and projected double-digit sales growth; integrated RiseBar into its healthy foods portfolio with channel expansions and new offerings; launched an enhanced Brand Partner compensation plan and several upgraded products at its Global Convention; and extended its sponsorship partnership with the Jamaica Bobsleigh and Skeleton Federation through additional Olympic cycles.

Company News

  • Protein Pop Launches Protein Pop Balance, a Clear Prebiotic Soda with 15 Grams of Protein and 5 Grams of Fiber

  • USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act

  • USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix

  • Why Usana Health Sciences Stock Plummeted This Week

  • USANA Health Sciences Q2 Earnings Call Highlights

  • USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade)

  • USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript

  • USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August

  • USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates

  • USANA Health Sciences Reports Second Quarter 2026 Results

  • New 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow

  • USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, Deepening Commitment to Clean Sport and Elite Athlete Nutrition

  • USANA Schedules Second Quarter 2026 Earnings Release and Conference Call

  • Kevin Guest: World Cup Determination Shows the Power of Grit, Preparation, Persistence

  • 5 Low P/B Stocks That Investors Can Add to Their Portfolio in July

  • Should Value Investors Buy USANA Health Sciences (USNA) Stock?

  • 4 Value Stocks to Buy as Lower Energy Costs Strengthen Market Outlook

  • USANA Health Sciences: How The Restructuring Plan Makes It A Strong Buy

  • USANA Celebrates 10 Years of Making the World a Better Place During World Service Week

  • 5 Low Price-to-Book Stocks That Are Worth Buying in June